ReviewFrontiers in immunology2017

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

John P Veluchamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.